PromoCell® Primary Cancer Culture System: Reliable Selective Culture of Malignant Cells for Cancer Research

Reliable primary cancer culture models and in vitro assay systems are essential for cancer research that closely mimics patient tumors from sample isolation through downstream analysis.

Why Choose Primary Cancer Culture

• Selective malignant cell culture: Supports the selective culture of malignant cells derived from primary tumors or patient-derived xenografts for more relevant cancer research models.
• Reduced stromal interference: Helps prevent stromal overgrowth during the isolation of fresh tumor samples to improve recovery of malignant cell populations, reducing the need for additional depletion steps.
• Pure malignant cultures: Enables establishment of cultures of pure malignant cells within 4 to 6 weeks.
• Support for PDX studies: Enables the culture of PDX tumor models in vitro for advanced cancer model development.
• 3D cancer modeling: Supports three-dimensional mammosphere or tumorsphere culture to model tumor heterogeneity and treatment response.
• Translational relevance: Provides primary cells from relevant human tissues for disease modeling, translational research, and therapeutic development in cancer studies.
• Trusted cell identity: Uses ethically collected human primary cells validated for identity with definitive phenotypic markers to support reliable study design.

Key Components and Features

• Primary Cancer Culture System: Complete medium formulation for selective malignant cell culture from primary tumors or patient-derived xenografts (PDX), designed as the core of the primary cancer culture workflow.
• Selective culture architecture: Medium and culture system design that minimizes stromal overgrowth while promoting malignant cell outgrowth.
• 3D Tumorsphere Media XF: Serum-free, xenofree formulation supporting the culture of commonly used cancer cell lines as three-dimensional mammospheres or tumorspheres.
• Human Primary Cells: Authenticated human primary cells, available from dozens of human tissue sources, to be used in combination with the primary cancer culture media.
• 3D Culture Reagents: Advanced media and reagents are available for 3D culture from patient cancers.
• Cell Source and Identity Validation: Human primary cells are ethically collected and validated for identity with definitive phenotypic markers.
• Culture Protocol Portfolio: Primary cell culture protocols include tumor spheroid formation.
• Formulation Options: Defined and animal component-free formulation options are available within the cancer culture offering.
• Tissue Relevance: Primary cells are provided from relevant human tissues to match specific cancer indications or tissue origins.

Applications and Use Cases

• Selective malignant cell culture: Used for the selective culture of malignant cells extracted from primary tumors or patient-derived xenografts.
• Cancer sphere formation: Used to support cancer sphere–based functional assays and downstream analyses.
• Cell line enrichment: Applied in workflows that enrich malignant cell lines from tumor-derived samples.
• Stromal cell depletion: Used in applications that include stromal cell depletion during primary cancer culture.
• In vitro PDX culture: Enables the culture of patient-derived xenograft tumor models in vitro.
• Disease modeling: Supports disease modeling with primary cells from relevant human tissues for translational research and therapeutic development in cancer studies.
• PDX-based research applications: PDX models have potential for drug screening, biomarker discovery, and the development of novel therapeutic approaches that include personalized medicine approaches to treatment.

Cancer Cell Culture Media

With over 23 years of expertise, Chemical Express is the official distributor of Merck and PromoCell in Thailand. Researchers can confidently purchase the PromoCell® Primary Cancer Culture System and related primary cancer culture products directly through Chemical Express, ensuring genuine quality and reliable support for all your cancer research needs.

“`